Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence

Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy. Therapy with anti-tumor necrosis factor (TNF)-α agents represents the first therapeutic choice for moderate and severe forms; however, PsA patients can experience anti-TNFα failure, lack of efficacy, or adverse events. Several evidence...

詳細記述

保存先:
書誌詳細
出版年:Drugs R D
主要な著者: Costa, Luisa, Perricone, Carlo, Chimenti, Maria Sole, Del Puente, Antonio, Caso, Paolo, Peluso, Rosario, Bottiglieri, Paolo, Scarpa, Raffaele, Caso, Francesco
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2017
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5694428/
https://ncbi.nlm.nih.gov/pubmed/29058302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-017-0215-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料